Home Consortium Increases healthcare footprint
- HomeCo (HMC) acquires eight private oncology assets with triple-net leases from GenesisCare for $110.3 million
- The nationwide property portfolio from GenesisCare, a worldwide cancer care provider, was purchased in a sale-and-leaseback transaction
- The company has also established a joint venture with operator Acurio Health Group to acquire and develop a five-hectare private hospital in Camden
- ASX-listed HealthCo REIT and Unlisted Institutional Fund are on-track for establishment by calendar year-end, the company said
- HomeCo announced that Chris Roberts, former CEO of Cochlear, has joined the proposed board of ASX-listed HealthCo
- Shares in Home Consortium are up 0.19 per cent, trading at $5.37 per share at 12:00 pm AEST
